日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Induction Chemotherapy Followed by Immunotherapy Increases Pathological Complete Response Rate in dMMR/MSI-H Gastric Cancer: A Retrospective Cohort Study

诱导化疗联合免疫治疗可提高dMMR/MSI-H胃癌的病理完全缓解率:一项回顾性队列研究

Zeng, Hong; Wu, Yingying; Zhang, Ziwei; Liu, Jingdong; Sun, Jie; Liu, Xinyou; Gu, Yuan; Tian, Mengxin; Chen, Weidong; Shen, Zhenbin; Shen, Kuntang; Xu, Chen; Wang, Xuefei; Tang, Zhaoqing; Sun, Yihong

Blockade of CLEVER-1 restrains immune evasion and enhances anti-PD-1 immunotherapy in gastric cancer

阻断CLEVER-1可抑制免疫逃逸并增强胃癌中抗PD-1免疫疗法的疗效

Yu, Kuan; Cao, Yifan; Zhang, Zihao; Wang, Leihao; Gu, Yichao; Xu, Tianwei; Zhang, Xiaolei; Guo, Xinxin; Shen, Zhenbin; Qin, Jing

TREM2 facilitates gastric cancer progression and immune evasion via inhibiting TRIM21-mediated STAT1 degradation in tumor-associated macrophages

TREM2通过抑制肿瘤相关巨噬细胞中TRIM21介导的STAT1降解,促进胃癌进展和免疫逃逸。

Zhang, Zihao; Yu, Kuan; Cao, Yifan; Xie, Peiyi; Wang, Leihao; Shen, Zhenbin; Qin, Jing

Blockade of V-domain immunoglobulin suppressor of T-cell activation reprograms tumour-associated macrophages and improves efficacy of PD-1 inhibitor in gastric cancer

阻断V结构域免疫球蛋白抑制T细胞活化可重编程肿瘤相关巨噬细胞,并提高PD-1抑制剂在胃癌中的疗效

Cao, Yifan; Yu, Kuan; Zhang, Zihao; Gu, Yun; Gu, Yichao; Li, Wandi; Zhang, Weijuan; Shen, Zhenbin; Xu, Jiejie; Qin, Jing

Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA)

对于存在单一不可治愈因素的胃癌患者,新辅助化疗(多西他赛、奥沙利铂和S-1(DOS方案))后行手术切除是否获益?一项多中心前瞻性队列研究(Neo-REGATTA)

Cui, Yuehong; Yu, Yiyi; Zheng, Song; Ying, Jie'er; Du, Yi'an; Wang, Yan; Wang, Xuefei; Shen, Zhenbin; Liu, Fenglin; Lv, Minzhi; Sun, Yihong; Liu, Tianshu

Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial

新辅助阿帕替尼联合奥沙利铂和卡培他滨治疗局部晚期胃或胃食管交界处腺癌患者:一项单臂、开放标签的II期试验

Tang, Zhaoqing; Wang, Yan; Yu, Yiyi; Cui, Yuehong; Liang, Liang; Xu, Chen; Shen, Zhenbin; Shen, Kuntang; Wang, Xuefei; Liu, Tianshu; Sun, Yihong

Tumor size and perineural invasion predict outcome of gastric high-grade neuroendocrine neoplasms

肿瘤大小和神经周围浸润可预测胃高级别神经内分泌肿瘤的预后

Zhang, Qi; Wang, Hongshan; Xie, Yanhong; Huang, Suming; Chen, Ke; Ye, Botian; Yang, Yupeng; Sun, Jie; He, Hongyong; Liu, Fenglin; Shen, Zhenbin; Chen, Weidong; Shen, Kuntang; Ji, Yuan; Sun, Yihong

NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer

NOTCH3是胃癌的预后因素,且与免疫耐受相关

Cui, Yuehong; Li, Qian; Li, Wei; Wang, Yan; Lv, Fang; Shi, Xinying; Tang, Zhaoqing; Shen, Zhenbin; Hou, Yingyong; Zhang, Henghui; Mao, Beibei; Liu, Tianshu

Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO-CLASSIC Study

奥沙利铂联合卡培他滨用于局部晚期胃腺癌围手术期治疗,并联合D2胃切除术:NEO-CLASSIC研究

Yu, Yiyi; Fang, Yong; Shen, Zhenbin; Wang, Yan; Yan, Min; Cao, Hui; Liu, Yingbin; Wang, Xuefei; Cui, Yuehong; Liu, Fenglin; Chen, Weidong; Li, Wei; Li, Qian; Jiang, Huiqin; Sun, Yihong; Liu, Tianshu

Outcomes of gastrectomy following upfront chemotherapy in advanced gastric cancer patients with a single noncurable factor: a cohort study

晚期胃癌患者接受一线化疗后行胃切除术的预后:一项队列研究

Li, Wei; Jiang, Huiqin; Yu, Yiyi; Wang, Yan; Wang, Zhiming; Cui, Yuehong; Shen, Kuntang; Shen, Zhenbin; Fang, Yong; Liu, Tianshu